Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenoprotein O like, pseudogene (SELENOOLP) is a non-coding genomic locus that resembles the sequence of selenoprotein O, but contains mutations or structural alterations that prevent it from being translated into a functional protein[3][1]. Pseudogenes arise through duplication and mutation of functioning genes; while some may retain partial sequence conservation or regulatory features, SELENOOLP has no known role in human biology and does not function as an enzyme, receptor, or other therapeutic target. Pseudogenes like SELENOOLP are usually annotated for completeness in genomic databases but do not have direct relevance for drug discovery or disease research unless rare regulatory functions are discovered[3][1]. If you intended a therapeutic target, consider verifying whether you meant "Selenoprotein O" (gene symbol SELENOO)[5], which is a functional mitochondrial selenoprotein potentially involved in redox regulation, not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenoprotein O like, pseudogene (SELENOOLP).